Viloxazine hydrochloride is a chemical compound that belongs to the class of selective norepinephrine reuptake inhibitors (NRI). It is primarily used as a medication for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents. Viloxazine hydrochloride works by increasing the levels of norepinephrine - a neurotransmitter in the brain that is involved in various functions including attention, arousal, and impulse control.
As an ADHD medication, viloxazine hydrochloride helps improve attention span, reduce hyperactivity, and control impulsiveness. It is believed to work by blocking the reuptake of norepinephrine, increasing its availability in the brain and enhancing its effects on cognition and behavior.
In addition to its use in ADHD, viloxazine hydrochloride has also been investigated for its potential efficacy in treating other conditions such as major depressive disorder and panic disorder. However, its use for these conditions is not yet approved in many countries.
Viloxazine hydrochloride is typically administered orally in the form of tablets or extended-release capsules. The dosage and duration of treatment are determined by a healthcare professional based on individual factors and response to the medication. Like any medication, it may cause side effects such as nausea, headache, dizziness, and insomnia, although these are generally well-tolerated.
It is important for individuals taking viloxazine hydrochloride to be monitored regularly by their healthcare provider to assess its effectiveness and evaluate any potential side effects.
